To evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing.

Biomanufacturing company Multiply Labs is using Nvidia technologies to develop robotic biomanufacturing systems for ...

Multiply Labs' goal is to enable scalable, high-throughput manufacturing while maintaining rigorous quality and regulatory standards.

Collaboration with AstraZeneca will focus on scaling cell therapy manufacturing using GMP-ready end-to-end robotic ...

Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is now leveraging NVIDIA's open ...